Recent Updates
Recently added Catalysts
OCS Neutral Sentiment

Oculis Publishes Consolidated Q2 Financial Statements and MD&A

Tuesday, August 27, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Oculis has published its Consolidated Q2 Financial Statements and Management Discussion and Analysis (MD&A). The announcement was made via a press release, and the documents have been filed with the SEC on form 6-K. This update provides stakeholders with insights into the company's financial performance for the second quarter.
Price reaction · baseline $11.85 (2024-08-26 close) · hit after-hours · 1 other OCS headline(s) in the window, move may be shared
day 0 close
+0.5%

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
3.8%
average across 4 past catalysts
Lead asset
Privosegtor
Phase 3 · Optic Neuritis

Full Press Release Details

ZUG, Switzerland, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Following the Company‘s press release published earlier today, the Q2 Consolidated Financial Statements and the MD&A, which have now been filed with the SEC on form 6-K, are attached.
Oculis Q2 Unaudited Condensed Consolidated Interim Financial Statements

Frequently Asked Questions

What was released by the company on August 27, 2024?

The company released its Q2 Consolidated Financial Statements and MD&A.

Where have the financial statements been filed?

They have been filed with the SEC on form 6-K.

What type of financial statements were discussed?

The statements are Q2 Unaudited Condensed Consolidated Interim Financial Statements.

ShareAdd on Google
Tags: OCS Viatris Investor Conferences Healthcare Oculis Q2 Financial Statements MD&A SEC
Last updated: Aug 27, 2024

Biotech snapshot

Lead asset
PrivosegtorPhase 3
Optic Neuritis →

Catalyst track record

+32%
best trade around OCS's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for OCS.

See every catalyst's timing & PoA →